<DOC>
	<DOCNO>NCT02258087</DOCNO>
	<brief_summary>Investigators compare randomize clinical trial result side effect high-dose- low-dose-rate brachytherapy monotherapy treatment early , organ confine prostate cancer patient .</brief_summary>
	<brief_title>HDR v LDR Brachytherapy Monotherapy Treatment Localized Prostate Cancer .</brief_title>
	<detailed_description>Permanent implant prostate brachytherapy ( LDRPBT ) well establish prove method treatment patient low select intermediate risk , organ confine prostate cancer . There number study high-dose rate brachytherapy ( HDRPBT ) monotherapy several fractionation schedule treat group patient . One phase II trial show effectiveness give one fraction 19 Gy . In trial investigator randomly select patient treat either LDR prostate brachytherapy ( 145Gy ) HDR prostate brachytherapy ( 1x19Gy ) monotherapy . Patients stratify two pretreatment group : 1. low risk , 2. select intermediate risk group . Brachytherapy give spinal anaesthesia , use transrectal ultrasound base real time treatment planning . Dose constraint define method .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>Eastern Cooperative Oncology Group ( ECOG ) status &lt; =1 4075 year old expect life expectancy &gt; 10 year low risk prostate cancer ( Prostate specific antigen ( PSA ) &lt; =10ng/ml , gleason score &lt; 7 , T status &lt; =2a ) , less 50 % positive biopsy core select intermediate prostate cancer ( PSA ) =10 &lt; 15ng/ml gleason score =3+4 ( 4+3 ) , T2bc , less 50 % positive biopsy core ) International prostate symptom score ( IPSS ) &lt; =15 Prostate volume &lt; =50cm3 pubic interference prior prostate operation , except biopsy prior radiation pelvis patient sign informed consent &lt; 40 year &gt; 75 year old PSA &gt; 15 ng/ml gleason score 4+3 , score 810 ECOG &gt; =2 T34 percent core positivity &gt; 50 % TUR operation within six month prior brachytherapy prostate volume &lt; 10 cm3 &gt; 50 cm3 IPSS &gt; 15</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Prostate , Cancer , Brachytherapy , HDR , LDR , monotherapy</keyword>
</DOC>